Skip to main content

Coronavirus (COVID-19): Visitor Restrictions, Resources, and Updates

Explore URMC
menu
Wilmot Cancer Institute / Research / Research Programs / Cancer Prevention & Control
 

Cancer Prevention and Control

doctors at benchThe Cancer Prevention and Control program covers the gamut from preventing cancer, particularly in high-risk groups, to conducting research in such areas as exercise oncology, health disparities, and geriatric oncology. Our focus is on improving treatment-related side effects and toxicities. Our success stems from being one of the first cancer control and population science programs in the nation.

Working directly with patients, survivors and caregivers, Wilmot’s CPC Program focuses its expertise and resources on the following specific aims:

  • Identify interventions to reduce cancer risk for individuals with a high probability for a cancer diagnosis
  • Develop effective supportive care therapies for patients, survivors, and caregivers to mitigate the toxicities and side effects caused by cancer and its treatments
  • Develop effective system-level supportive care interventions for oncology practices and healthcare systems to improve cancer-care delivery and outcomes

PEAK lab

Program Leaders

MustianKaren Mustian, Ph.D., M.P.H.

Dean’s Professor of Surgery, Cancer Control

Dr. Mustian focuses on the role of physical activity and exercise on cancer- and treatment-related side effects.

MohileSupriya Mohile, M.D., M.S.

Philip and Marilyn Wehrheim Professor of Medicine, Hematology/Oncology

Dr. Mohile conducts research focused on improving cancer care delivery for older adults.